An atrial fibrillation device maker has 70% upside, JMP Securities says
Investors should scoop up shares of medical device provider AtriCure , according to JMP Securities, which expects the company to be a winner in one burgeoning medical device market. Analyst Daniel Stauder initiated coverage of the stock…
Read More...
Read More...